Anesthetic management with labor epidural analgesia of the parturient with severe factor VII deficiency: a case report.

IF 5.1 2区 医学 Q1 ANESTHESIOLOGY
Benjamin Hyers, Camila Cabrera, Christopher Walsh, Anusha Reddy, Talia Strulowitz, Joshua Hamburger, Nakiyah Knibbs, Daniel Katz, Lauren Ferrara, Yaakov Beilin
{"title":"Anesthetic management with labor epidural analgesia of the parturient with severe factor VII deficiency: a case report.","authors":"Benjamin Hyers, Camila Cabrera, Christopher Walsh, Anusha Reddy, Talia Strulowitz, Joshua Hamburger, Nakiyah Knibbs, Daniel Katz, Lauren Ferrara, Yaakov Beilin","doi":"10.1136/rapm-2024-105674","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Factor VII deficiency is considered a contraindication to neuraxial anesthesia due to the risk of an epidural hematoma.</p><p><strong>Case report: </strong>A 32 year old G1P0 parturient with severe factor VII deficiency presented for an anesthesiology consultation at 32 weeks gestation. Initial coagulation studies were significant for an elevated INR (2.0) and a low factor VII level of 6%. After interdisciplinary discussion, it was decided that neuraxial analgesia could be offered if her coagulation studies corrected after administration of recombinant activated factor VII (rFVIIa). The patient presented at 36 weeks gestation for a rFVIIa challenge. She received 22 mcg/kg rFVIIa and coagulation studies were analyzed 20 minutes later which showed complete correction of the coagulopathy. The patient presented to the hospital at 39 weeks and 3 days for delivery, received 2 mg rFVIIa and 20 minutes later, successfully received an epidural catheter. Her INR was monitored every 3 hours during her labor course and rFVIIa was given if the INR was 1.3 or greater. She required three additional doses over 22 hours. No bleeding or thrombotic events occurred, and the patient was discharged home without complications.</p><p><strong>Conclusion: </strong>This case highlights the safe management of an epidural catheter in a parturient with severe factor VII deficiency.</p>","PeriodicalId":54503,"journal":{"name":"Regional Anesthesia and Pain Medicine","volume":null,"pages":null},"PeriodicalIF":5.1000,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regional Anesthesia and Pain Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/rapm-2024-105674","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Factor VII deficiency is considered a contraindication to neuraxial anesthesia due to the risk of an epidural hematoma.

Case report: A 32 year old G1P0 parturient with severe factor VII deficiency presented for an anesthesiology consultation at 32 weeks gestation. Initial coagulation studies were significant for an elevated INR (2.0) and a low factor VII level of 6%. After interdisciplinary discussion, it was decided that neuraxial analgesia could be offered if her coagulation studies corrected after administration of recombinant activated factor VII (rFVIIa). The patient presented at 36 weeks gestation for a rFVIIa challenge. She received 22 mcg/kg rFVIIa and coagulation studies were analyzed 20 minutes later which showed complete correction of the coagulopathy. The patient presented to the hospital at 39 weeks and 3 days for delivery, received 2 mg rFVIIa and 20 minutes later, successfully received an epidural catheter. Her INR was monitored every 3 hours during her labor course and rFVIIa was given if the INR was 1.3 or greater. She required three additional doses over 22 hours. No bleeding or thrombotic events occurred, and the patient was discharged home without complications.

Conclusion: This case highlights the safe management of an epidural catheter in a parturient with severe factor VII deficiency.

对患有严重 VII 因子缺乏症的产妇进行分娩硬膜外镇痛的麻醉管理:病例报告。
背景:由于存在硬膜外血肿的风险,因子 VII 缺乏症被认为是神经麻醉的禁忌症:一名 32 岁的 G1P0 孕产妇患有严重的因子 VII 缺乏症,在妊娠 32 周时前来麻醉科就诊。初步凝血检查显示 INR 升高(2.0),Ⅶ因子水平低至 6%。经过多学科讨论,决定如果患者在使用重组活化因子 VII(rFVIIa)后凝血研究结果得到纠正,则可以提供神经轴镇痛。患者在妊娠 36 周时接受了 rFVIIa 挑战。她接受了 22 微克/千克的 rFVIIa,20 分钟后对凝血研究进行了分析,结果显示凝血病完全得到纠正。患者在 39 周零 3 天时到医院待产,接受了 2 毫克 rFVIIa,20 分钟后成功接受了硬膜外导管。在分娩过程中,每 3 小时对她的 INR 进行一次监测,如果 INR 为 1.3 或更高,则给予 rFVIIa。在 22 个小时内,她需要额外服用三次。没有发生出血或血栓事件,患者无并发症出院回家:本病例强调了对患有严重 VII 因子缺乏症的产妇使用硬膜外导管的安全管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
8.50
自引率
11.80%
发文量
175
审稿时长
6-12 weeks
期刊介绍: Regional Anesthesia & Pain Medicine, the official publication of the American Society of Regional Anesthesia and Pain Medicine (ASRA), is a monthly journal that publishes peer-reviewed scientific and clinical studies to advance the understanding and clinical application of regional techniques for surgical anesthesia and postoperative analgesia. Coverage includes intraoperative regional techniques, perioperative pain, chronic pain, obstetric anesthesia, pediatric anesthesia, outcome studies, and complications. Published for over thirty years, this respected journal also serves as the official publication of the European Society of Regional Anaesthesia and Pain Therapy (ESRA), the Asian and Oceanic Society of Regional Anesthesia (AOSRA), the Latin American Society of Regional Anesthesia (LASRA), the African Society for Regional Anesthesia (AFSRA), and the Academy of Regional Anaesthesia of India (AORA).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信